{"id":"W2947120195","doi":"10.1200/jco.2019.37.15_suppl.5539","title":"Adverse events (AEs) with maintenance olaparib in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Phase III SOLO1 trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Adverse effect; Internal medicine; Neutropenia; Nausea; Placebo; Vomiting; Anemia; Surgery; Oncology; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009625627,0.0006019966,0.000765815,0.0001641826,0.0001657983,0.0004655649,0.0004090378,0.0005212844,0.003474275],"category_scores_gemma":[0.000803866,0.0002312195,0.00111769,0.0002889922,0.0002517898,0.0003209034,0.0002280872,0.001092743,0.0002486906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005276298,"about_ca_system_score_gemma":0.0005820032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003220986,"about_ca_topic_score_gemma":0.001257804,"domain_scores_codex":[0.9997666,0.0001145012,0.00002277961,0.00004460389,0.00002874457,0.00002279435],"domain_scores_gemma":[0.9993924,0.0001442476,0.0002835055,0.00001779173,0.0000229817,0.0001390534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7566223,0.005631724,0.02933623,0.004562804,0.003551922,0.0003083152,0.0001801189,0.001695334,0.01557874,0.0001831622,0.005453436,0.176896],"study_design_scores_gemma":[0.7572767,0.1646788,0.06300199,0.0004334515,0.00286458,0.001366089,0.00006716121,0.002078773,0.002923506,0.0003376625,0.004933022,0.00003819566],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835549,0.01175894,0.0003209476,0.0003920468,0.00006278071,0.0009777745,0.001367046,0.00004452617,0.001521101],"genre_scores_gemma":[0.9902322,0.004341018,0.0007776283,0.0005525305,0.0001386615,0.001019716,0.001849645,0.000007705565,0.001080661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003474275,"threshold_uncertainty_score":0.01162255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04655180867685195,"score_gpt":0.4359048671981457,"score_spread":0.3893530585212938,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}